4.1 Article Retracted Publication

被撤回的出版物: CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: A meta-analysis (Retracted article. See April, 2017)

Related references

Note: Only part of the references are listed.
Review Oncology

Genetic susceptibility to lung cancerulight at the end of the tunnel?

Ariela L. Marshall et al.

CARCINOGENESIS (2013)

Article Oncology

Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study

Sofia Pavanello et al.

CANCER GENETICS (2012)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Medicine, General & Internal

Non-small-cell lung cancer

Peter Goldstraw et al.

LANCET (2011)

Review Oncology

Genetics of lung-cancer susceptibility

Paul Brennan et al.

LANCET ONCOLOGY (2011)

Review Public, Environmental & Occupational Health

GENETIC POLYMORPHISM OF METABOLIC ENZYMES P450 (CYP) AS A SUSCEPTIBILITY FACTOR FOR DRUG RESPONSE, TOXICITY, AND CANCER RISK

Nada Bozina et al.

ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2009)

Article Medicine, Research & Experimental

CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population

Fatma B'chir et al.

LIFE SCIENCES (2009)

Review Biochemistry & Molecular Biology

Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer

DW Nebert et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Biochemistry & Molecular Biology

Cigarette smoking, metabolic activation and carcinogenesis

A Nishikawa et al.

CURRENT DRUG METABOLISM (2004)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)